Novavax is showing promising setup characteristics, with a daily gap forming at the ~$7.00 level and a breakout above ~$9.75 poised to target resistance at ~$10.30. This trade offers a strong risk‑to‑reward profile, with a stop‑loss around $6.13.
Fundamentally, Novavax remains relevant in the biotech space, with its protein‑based COVID‑19 vaccine and active partnerships supporting its pipeline and future earnings potential.
From a technical standpoint, NVAX is volatile—but that same volatility can provide opportunity. Its large single‑day moves reflect high upside potential when market sentiment aligns.
While the shorter‑term target is $10.28, the longer‑term view could see NVAX revisiting higher levels, such as ~$14.58, assuming its pipeline momentum and technical patterns align.
Overall, with a well‑defined entry, tight stop‑loss, and clear target, NVAX presents a high‑risk/high‑reward opportunity worth watching.
https://www.tradingview.com/x/N4eS2SNs/
Fundamentally, Novavax remains relevant in the biotech space, with its protein‑based COVID‑19 vaccine and active partnerships supporting its pipeline and future earnings potential.
From a technical standpoint, NVAX is volatile—but that same volatility can provide opportunity. Its large single‑day moves reflect high upside potential when market sentiment aligns.
While the shorter‑term target is $10.28, the longer‑term view could see NVAX revisiting higher levels, such as ~$14.58, assuming its pipeline momentum and technical patterns align.
Overall, with a well‑defined entry, tight stop‑loss, and clear target, NVAX presents a high‑risk/high‑reward opportunity worth watching.
https://www.tradingview.com/x/N4eS2SNs/
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.